株式会社タイミー Logo

株式会社タイミー

On-demand staffing platform connecting businesses and workers for flexible spot work.

215A | T

Overview

Corporate Details

ISIN(s):
JP3449040009
LEI:
Country:
Japan
Address:
東京都港区東新橋1丁目5ー2 汐留シティセンター35階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Timee, Inc. operates "Timee," a leading on-demand staffing platform that connects individuals seeking flexible, short-term work with businesses facing immediate labor needs. The service functions as a "spot work" marketplace, allowing users to find and work jobs without the need for traditional applications or interviews, often with the benefit of same-day payment. For businesses, Timee offers a swift solution to labor shortages and fluctuating staffing demands, particularly in sectors like hospitality, logistics, and retail. The company's mission is to create a new infrastructure for work that expands individual potential and helps solve broader societal challenges related to employment.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-12 08:30
Interim Report
確認書
Japanese 8.7 KB
2025-06-12 08:30
Interim Report
半期報告書-第9期(2024/11/01-2025/10/31)
Japanese 213.1 KB
2025-01-29 07:31
Post-Annual General Meeting Information
臨時報告書
Japanese 21.1 KB
2025-01-29 07:31
Registration Form
確認書
Japanese 8.7 KB
2025-01-29 07:30
Registration Form
有価証券報告書-第8期(2023/11/01-2024/10/31)
Japanese 2.5 MB
2025-01-29 07:30
Governance Information
内部統制報告書-第8期(2023/11/01-2024/10/31)
Japanese 22.5 KB
2024-07-18 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 1.9 MB
2024-07-18 08:00
Share Issue/Capital Change
訂正臨時報告書
Japanese 34.2 KB
2024-07-16 08:00
Registration Form
臨時報告書
Japanese 28.6 KB
2024-07-16 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 1.8 MB
2024-07-09 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 1.9 MB
2024-07-09 08:00
Share Issue/Capital Change
訂正臨時報告書
Japanese 33.4 KB
2024-07-03 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 1.8 MB
2024-06-21 08:00
Share Issue/Capital Change
臨時報告書
Japanese 29.5 KB
2024-06-21 08:00
Registration Form
有価証券届出書(新規公開時)
Japanese 3.6 MB

Automate Your Workflow. Get a real-time feed of all 株式会社タイミー filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 株式会社タイミー

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 株式会社タイミー via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Groupe CRIT Logo
International provider of human resources, airport assistance, and industrial services.
France
CEN
Gubra A/S Logo
CRO & biotech accelerating peptide drug discovery for metabolic and fibrotic diseases.
Denmark
GUBRA
HACKETT GROUP, INC. Logo
IP-based strategic advisory on Gen AI and digital transformation for global enterprises.
United States of America
HCKT
HALOZYME THERAPEUTICS, INC. Logo
Licenses a drug delivery platform to biopharma, converting IV drugs to subcutaneous injections.
United States of America
HALO
HANATOUR JAPAN CO.,LTD. Logo
B2C/B2B travel firm providing packages, MICE, and inbound services, with a focus on Korea.
Japan
6561
HANATOUR SERVICE INC. Logo
South Korea's top travel firm offering package tours and custom trips for B2C & B2B clients.
South Korea
039130
Hanmi Science Co.,Ltd Logo
A holding company managing R&D-focused pharmaceutical, API, and medical device firms.
South Korea
008930
Haoxi Health Technology Ltd Logo
An online marketing solutions provider for the healthcare industry, focusing on video and news feed ads.
United States of America
HAO
Heidelberg Pharma AG Logo
Develops cancer therapies using its proprietary ATAC Antibody-Drug Conjugate technology.
Germany
HPHA
HighCo Logo
Data marketing firm offering digital solutions for brands & retailers to influence shopper behavior.
France
HCO

Talk to a Data Expert

Have a question? We'll get back to you promptly.